AIDS Weekly

HIV/AIDS Research - Pharma company announces HIV drug candidate trial results

HIV/AIDS Research - Phase 1 trial results for HIV treatment announced

HIV/AIDS Research - Reports advance knowledge in HIV/AIDS research

HIV/AIDS Research - Study of AIDS-blocking pill progressing

HIV/AIDS Resistance - Biologists discover why 10% of Europeans are safe from HIV infection

HIV/AIDS Risk Behavior - Alcohol use associated with HIV risk behavior among rural adolescents

HIV/AIDS Testing - Early detection of kidney dysfunction in HIV patients using new marker studied

HIV/AIDS Testing - Utility of virologic assays in HIV management discussed iat conference

HIV/AIDS Therapy - Antifungal peptide inhibits leukemia proliferation and HIV-1-RT activity

HIV/AIDS Therapy - BioScience company announces data from HIV treatment program

HIV/AIDS Therapy - Study examines lessons learned at Africa's first public antiretroviral clinic

HIV/AIDS Therapy - Two chemicals boost immune cells' ability to fight HIV without gene therapy

HIV/AIDS Therapy - Variable molecular structures contribute to protease inhibitor resistance

HIV/AIDS Vaccine - DermaVir is a new topical vaccine for HIV/AIDS

HIV/AIDS Vaccine - E-communications company teams with U2's Bono to combat AIDS, poverty in Africa

HIV/AIDS Vaccine - Experiences of men who have sex with men with risk counseling reported

HIV/AIDS Vaccine - HIV genomic RNA sequences in female genital tract and blood reported

HIV/AIDS Vaccine - Innate immunity in experimental SIV infection and vaccination explored

HIV/AIDS Vaccines - Researchers' data advance HIV/AIDS vaccines research

HIV/AIDS-Associated Disorder - Acquired rectal fistula may be sign of HIV infection in children

HIV/AIDS-Associated Virus - CNS DNA/RNA virus types depend on whether immunocompetent or immunocompromised

Heart Disease Risk - HIV is not an independent risk factor for severe heart disease

Hematology - New research in the area of hematology detailed

Hepatitis C Therapy - FDA approves drug combination as first hepatitis C treatment for HIV patients

Hepatitis C Virus - U.S. FDA approves Pegasys and Copegus as hepatitis C treatment for HIV patients

Human Herpesvirus-8 Infection - Sociological risk factors determined for HHV8 infection in cancer patients

Human Papillomavirus - Subsequent HPV risk in HIV+ women not lowered by natural infection

Kidney Disease - National survey finds high correlation between kidney disease and risk factors

Malignant Gliomas - FDA clears phase I/II recurrent malignant gliomas clinical trial

Mergers & Acquisitions - Majority control of TherapyEdge acquired

Mother-to-Child HIV Transmission - Program evaluation in Bangkok finds factors that hinder women's use of services

Multiple Sclerosis - Multiple sclerosis microarray studies with RPI-78M analysis completed

Multiple Sclerosis Vaccine - Phase 2 study on safety, dosing of vaccine for multiple sclerosis announced

Obesity - High-fat diet alters homeostatic regulation of energy balance

Pharmaceutical Research - Scientists' findings show regulation of immune cell memory

Respiratory Syncytial Virus - Research company expands distribution for monoclonal antibodies against RSV

Sexually Transmitted Infection - Exploring sexual networks yields insights into sexually transmitted infections

Sexually Transmitted Infection - Presumptive periodic treatment an ineffective anti-HIV strategy in sex workers

Syphilis - Syphilis rates increasing around the world

Vaccines Development - Researchers provide details of new studies and findings in the area of vaccines development